Peter Witzleb has extensive experience in information technology and strategic leadership roles. Peter is currently the Director of Information Technology at The Association for Frontotemporal Degeneration (AFTD). Prior to this, they served as the Vice President of Information Services at Fresenius Medical Care North America, where they provided vision, leadership, and operational support for the company's IS department. Peter also worked as an Independent Consultant at Witzleb Associates, specializing in healthcare IT projects for non-profit organizations. Peter Witzleb has held positions such as Director of Technology at The Episcopal Academy and Senior Director of Research Information Systems at the Children's Hospital of Philadelphia. Peter started their career as a Project Director/Manager at the Web Technology Group of the University of Rochester Medical Center. Overall, Peter Witzleb's experience spans a variety of industries and includes strategic planning, leadership, and technical expertise.
Peter Witzleb earned a Bachelor of Arts degree in Psychology from the University of Rochester, where they studied from 1991 to 1995. Following this, they pursued a Master of Business Administration (M.B.A.) from the University of Rochester - Simon Business School, specializing in Information Systems, Electronic Commerce, and Competitive Strategy, from 1997 to 2000.
This person is not in any teams
The Association for Frontotemporal Degeneration (AFTD)
AFTD establish an institution dedicated to advancing FTD research, providing information, education, and support, as well as raising awareness of this uncommon and especially devastating disease, the AFTD, in whom mission is to improve the quality of life for those affected by FTD and drive research toward a cure, collaborated with a collective ofdedicated FTD care partners and medical professionals. With a committed board of directors, a robust volunteer network, and medical and scientific advisers from the leading experts from across the world, the company has developed into a major international structure on FTD and young onset dementia. AFTD has profited from kind foundation and donor funding, including gifts from the fund.